SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy

Clin Chim Acta. 2021 Oct:521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.

Abstract

SLC37A4-CDG is an emerging congenital disorder of glycosylation which is characterized by a dominant inheritance and a major coagulopathy originating from the liver. Recent studies took interest in the biochemical alterations found in this CDG and showed that they consisted of multiple glycosylation abnormalities, which result from mislocalization of the endoplasmic reticulum glucose-6-phosphate transporter and associated Golgi homeostasis defects. In this work, we highlight in six affected individuals abnormal patterns for various serum N-glycoproteins and bikunin proteoglycan isoforms, together with specific alterations of the mass spectra of endoglycosidase H-released serum N-glycans. Collectively, these data complement previous findings, help to better delineate SLC37A4-CDG and could present interest in diagnosing this disease.

Keywords: Bikunin; CDG; Coagulopathy; SLC37A4.

MeSH terms

  • Antiporters / metabolism
  • Congenital Disorders of Glycosylation* / diagnosis
  • Congenital Disorders of Glycosylation* / genetics
  • Congenital Disorders of Glycosylation* / metabolism
  • Endoplasmic Reticulum / metabolism
  • Glycosylation
  • Golgi Apparatus
  • Humans
  • Monosaccharide Transport Proteins / genetics
  • Monosaccharide Transport Proteins / metabolism
  • Polysaccharides

Substances

  • Antiporters
  • Monosaccharide Transport Proteins
  • Polysaccharides
  • SLC37A4 protein, human